SCM
EW icon

Sio Capital Management’s Edwards Lifesciences EW Stock Holding History

Sio Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-165,000
Closed -$5.15M – 55
2016
Q4 		$5.15M Buy
+165,000
New +$5.35M 3.01% 10

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sio Capital Management's EW Position: Q1 2017 in Review

Sio Capital Management sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 165,000 shares — an estimated $5.15M sold.

Sio Capital Management first reported a position in EW in Q4 2016 and held it in 1 quarter. The position peaked at $5.15M in Q4 2016. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • Sio Capital Management reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
  • Sio Capital Management sold 165,000 Edwards Lifesciences shares in Q1 2017, an estimated $5.15M.
  • Sio Capital Management first reported a position in Edwards Lifesciences in Q4 2016 and held it in 1 quarter.
  • Sio Capital Management's Edwards Lifesciences position peaked at $5.15M in Q4 2016.
  • 691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Sio Capital Management's 13F filing for Q1 2017, filed 15 May 2017.